121 related articles for article (PubMed ID: 28986588)
1. Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A.
Lee J; Lee J; Yun JH; Choi C; Cho S; Kim SJ; Kim JH
Sci Rep; 2017 Oct; 7(1):12760. PubMed ID: 28986588
[TBL] [Abstract][Full Text] [Related]
2. Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer.
Lee J; Lee J; Kim JH
Cancer Lett; 2019 Aug; 456():1-12. PubMed ID: 30902562
[TBL] [Abstract][Full Text] [Related]
3. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
Lee J; Lee J; Yun JH; Jeong DG; Kim JH
Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
[TBL] [Abstract][Full Text] [Related]
4. Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells.
Lee J; Hun Yun J; Lee J; Choi C; Hoon Kim J
Sci Rep; 2015 Jul; 5():12296. PubMed ID: 26212664
[TBL] [Abstract][Full Text] [Related]
5. DUSP28 promotes cell proliferation, migration, and invasion by Akt/β-catenin/Slug axis in breast cancer.
Zhang J; Guo Y
Acta Biochim Pol; 2022 Dec; 69(4):711-717. PubMed ID: 36520087
[TBL] [Abstract][Full Text] [Related]
6. DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling.
Wang D; Han S; Peng R; Jiao C; Wang X; Han Z; Li X
Int J Oncol; 2014 Dec; 45(6):2596-604. PubMed ID: 25230705
[TBL] [Abstract][Full Text] [Related]
7. β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer.
Kuo TL; Cheng KH; Shan YS; Chen LT; Hung WC
Theranostics; 2019; 9(2):324-336. PubMed ID: 30809277
[No Abstract] [Full Text] [Related]
8. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
9. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
10. Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic Cancer Cells Through Stimulation of Src and p38 Signalling Pathway.
Lee J; Lee J; Kim DH; Kim JH
Anticancer Res; 2020 Mar; 40(3):1335-1344. PubMed ID: 32132030
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
13. Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration.
Jalvy S; Renault MA; Leen LL; Belloc I; Bonnet J; Gadeau AP; Desgranges C
Cardiovasc Res; 2007 Sep; 75(4):738-47. PubMed ID: 17574222
[TBL] [Abstract][Full Text] [Related]
14. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.
Grimmig T; Moench R; Kreckel J; Haack S; Rueckert F; Rehder R; Tripathi S; Ribas C; Chandraker A; Germer CT; Gasser M; Waaga-Gasser AM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941651
[TBL] [Abstract][Full Text] [Related]
15. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
16. Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28.
Ku B; Hong W; Keum CW; Kim M; Ryu H; Jeon D; Shin HC; Kim JH; Kim SJ; Ryu SE
PLoS One; 2017; 12(11):e0187701. PubMed ID: 29121083
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
[TBL] [Abstract][Full Text] [Related]
19. Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway.
Li H; Shi B; Li Y; Yin F
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28266802
[TBL] [Abstract][Full Text] [Related]
20. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
